Clincosm LogoSign in Get a demo

Lymphoma

Showing 101 - 125 of 1,788
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Bone Metastases, Lymphoma, Multiple Myeloma Trial in Saint Louis (Ketorolac, Normal saline, Acetaminophen)

Recruiting
  • Bone Metastases
  • +4 more
  • Saint Louis, Missouri
    Saint Louis University
Dec 6, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 7, 2022

Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CAR-T Autologous T cell injection
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Dec 2, 2022

Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

Recruiting
  • Lymphoma
  • +7 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

Recruiting
  • Lymphoma
  • +4 more
  • iC9-CAR19 T cells
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Multiple Myeloma, Lymphoma Trial in China (Etoposide, Cyclophosphamide, Mecapegfilgrastim, day 2)

Recruiting
  • Multiple Myeloma
  • Lymphoma
  • Hefei, Anhui, China
  • +6 more
Dec 1, 2022

A Single-Site Tissue Repository Providing Annotated Biospecimens

Recruiting
  • Age-Related Macular Degeneration
  • +46 more
  • Specimen sample
  • Waltham, Massachusetts
    Sanguine Biosciences
Nov 22, 2022

Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)

Active, not recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
Nov 30, 2022

Solid Tumor, Lymphoma Trial in Beijing (CS1003 mAb)

Completed
  • Solid Tumor
  • Lymphoma
  • CS1003 monoclonal antibody
  • Beijing, China
  • +16 more
Nov 28, 2022

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Lymphoma, Leukemia Trial in United States (CPI-613)

Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
Nov 28, 2022

Solid Malignancy, Lymphoma Trial in New York ([18F] 4-L-Fluoroglutamine (2S,4R))

Recruiting
  • Solid Malignancy
  • Lymphoma
  • [18F] 4-L-Fluoroglutamine (2S,4R)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 28, 2022

Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Seattle (Survivorship Care Plan, Educational Intervention,

Enrolling by invitation
  • Breast Carcinoma
  • +4 more
  • Survivorship Care Plan
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 22, 2022

Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Lymphoma
  • Positron Emission Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Nov 18, 2022

Lymphoma Trial in United States (itacitinib, ibrutinib)

Completed
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
Nov 14, 2022

Advanced Solid Tumor, Lymphoma Trial in Australia, United States (ALPN-202)

Active, not recruiting
  • Advanced Solid Tumor
  • Lymphoma
  • Scottsdale, Arizona
  • +9 more
Nov 8, 2022

Lymphoma Trial in Worldwide (Bendamustine, Obinutuzumab, Polatuzumab vedotin (Liquid))

Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +61 more
Oct 18, 2022

Follicular Lymphoma, Lymphoma Trial in United States (Mosunetuzumab)

Recruiting
  • Follicular Lymphoma
  • Lymphoma
  • Basking Ridge, New Jersey
  • +6 more
Nov 9, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Ghent, Belgium
    • +28 more
    Nov 11, 2022

    Advanced Solid Tumor, Lymphoma Trial in United States (ALPN-202, Pembrolizumab)

    Active, not recruiting
    • Advanced Solid Tumor
    • Lymphoma
    • Atlanta, Georgia
    • +4 more
    Nov 8, 2022

    A Study of Chinese Adults With Lymphoma

    Recruiting
    • Lymphoma
      • Beijing, Beijing, China
      • +18 more
      Nov 3, 2022